These results indicated that PRKCZ hypermethylation might represent one possible reason why HPV+ HNSCC has a better prognosis and that blocking PRKCZ might be a new strategy for HPV+ HNSCC. This evidence concerns the gene PRKCZ and head and neck squamous cell carcinoma.